Sort
23,748 grants matching “melanoma”
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL
$328,810Ruth Halaban · Yale University · P50 · FY2008 · CA
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$328,761David M. Ashley · Duke University · U19 · FY2023 · CA
Biospecimen Procurement & Utilization Core
$328,722Richard Bernard Hayes · New York University School Of Medicine · P20 · FY2021 · CA
Deciphering macroH2A function in melanoma progression
$328,665Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · CA
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
$328,659Esteban Celis · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
BMP7 in melanoma niche morphogenesis and homeostasis
$328,581Mei-Yu Hsu · Boston University Medical Campus · R01 · FY2011 · CA
Multiscale microscope for 3D cancer imaging in model organisms and organoids
$328,541Reto Paul Fiolka · Ut Southwestern Medical Center · R33 · FY2019 · CA
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
$328,478Thomas B Tomasi · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
HEF1 Coordination of Cell Cycle, Migration, and Invasion in Cancer
$328,475Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2010 · CA
Defining the contribution of ATR to MC1R-enhanced DNA repair in melanocytes
$328,466John A Dorazio · University Of Kentucky · R01 · FY2019 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$328,454Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Immune responses to gene-modified, autologous dendritic cell vaccines in melanoma
$328,375James W. Young · Sloan-Kettering Inst Can Research · R21 · FY2006 · CA
Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma
$328,358Ann Richmond · Vanderbilt University · R01 · FY2012 · CA
Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma
$328,358Ann Richmond · Vanderbilt University · R01 · FY2011 · CA
PD-1 Abrogation and Immunity in Melanoma
$328,315Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Autophagy Modulation for Melanoma Therapy
$328,284Ravi K Amaravadi · Wistar Institute · P50 · FY2017 · CA
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$328,217John H Sampson · Duke University · P50 · FY2014 · CA
Biospecimen Procurement & Utilization Core
$328,185Richard Bernard Hayes · New York University School Of Medicine · P20 · FY2022 · CA
DNA sensors and associated signaling pathways in the innate immune response
$328,154Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · AI
Spectral Imaging of Melanoma Cell Adhesion & Metastasis
$328,148Dorothea Becker · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA
Targeting Evolving Therapy Resistance
$328,133Yael P Mosse · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Improving early detection of melanoma with skin self examination
$328,115Myles G Cockburn · University Of Southern California · R01 · FY2007 · CA
Signaling Pathways for UV-Induced Melanogenic Responses
$328,106University Of Cincinnati · R01 · FY2004 · ES
Signaling Pathways for UV-Induced Melanogenic Responses
$328,106University Of Cincinnati · R01 · FY2005 · ES
Cellular Pharmacology of Rapamycin
$328,104Gary G Chiang · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2006 · CA